A detailed history of Point72 Hong Kong LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 2,603 shares of MEDP stock, worth $1.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,603
Previous 1,304 99.62%
Holding current value
$1.05 Million
Previous $399,000 163.66%
% of portfolio
0.05%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $370,046 - $536,889
1,299 Added 99.62%
2,603 $1.05 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $296,686 - $407,734
1,304 New
1,304 $399,000
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $89,400 - $112,413
616 Added 218.44%
898 $141,000
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $36,716 - $47,384
282 New
282 $42,000
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $75,900 - $88,401
-446 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $28,710 - $35,168
181 Added 68.3%
446 $79,000
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $34,985 - $44,588
265 New
265 $43,000
Q1 2020

May 15, 2020

SELL
$61.71 - $101.95 $8,084 - $13,355
-131 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $9,180 - $11,087
131 New
131 $11,000
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $1,126 - $1,373
-21 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $1,036 - $1,482
21 New
21 $1,000
Q3 2018

Nov 14, 2018

SELL
$43.25 - $63.74 $13,407 - $19,759
-310 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $10,549 - $14,092
310 New
310 $13,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.